Water soluble usnic acid-polyacrylamide complexes with enhanced antimicrobial activity against Staphylococcus epidermidis

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 7356-7369

  Francolini, Iolanda ^a   Taresco, Vincenzo ^a   Crisante, Fernanda ^a   Martinelli, Andrea ^a   D'Ilario, Lucio ^a   Piozzi, Antonella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antimicrobial activity; Drug delivery; Polyacrylamide; Solubility; Usnic acid

Indexed keywords

POLYACRYLAMIDE; USNIC ACID; WATER; ACRYLIC ACID RESIN; ANTIINFECTIVE AGENT; BENZOFURAN DERIVATIVE;

ARTICLE; BACTERICIDAL ACTIVITY; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DOSAGE FORM COMPARISON; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; GROWTH INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MISCIBILITY; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS EPIDERMIDIS; THERMAL ANALYSIS; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; SOLUBILITY;

ACRYLIC RESINS; ANTI-INFECTIVE AGENTS; BENZOFURANS; SOLUBILITY; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84876000702     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14047356     Document Type: Article

References (32)

1. Veber, D.F.; Johnson, S.R.; Cheng, H.Y.; Smith, B.R.; Ward, K.V.; Kopple, K.D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002, 45, 2615-2623.
2. Cocchietto, M.; Skert, N.; Nimis, P.; Sava, G. A review on usnic acid: An interesting natural compound. Naturwissenschaften 2002, 89, 137-146.
3. Lauterwein, M.; Oethinger, M.; Belsner, K.; Peters, T.; Marre, R. In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob. Agents Chemother. 1995, 39, 2541-2543.
4. Ramos, D.F.; Almeida da Silva, P.E. Antimycobacterial activity of usnic acid against resistant and susceptible strains of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Pharm. Biol. 2010, 48, 260-263.
5. Pires, R.H.; Lucarini, R.; Mendes-Giannini, M.J. Effect of usnic acid on Candida orthopsilosis and C. parapsilosis. Antimicrob. Agents Chemother. 2012, 56, 595-597.
6. Francolini, I.; Norris, P.; Piozzi, A.; Donelli, G.; Stoodley, P. Usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces. Antimicrob. Agents Chemother. 2004, 48, 4360-4365.
7. Labib, M.E.; Brumlik, C.J.; Stoodley, P.; Dukhin, S.S.; Davidson, T.; Tabani, Y. The Long-term release of antibiotics from monolithic nonporous polymer implants for use as tympanostomy tubes. Colloids Surf. A 2010, 254, 331-337.
8. Kim, S.; Greenleaf, R.; Miller, M.C.; Satish, L.; Kathju, S.; Ehrlich, G.; Post, J.C.; Sotereanos, N.G.; Stoodley, P. Mechanical effects, antimicrobial efficacy and cytotoxicity of usnic acid as a biofilm prophylaxis in PMMA. J. Mater. Sci Mater. Med. 2011, 22, 2773-2780.
9. Piozzi, A.; Francolini, I.; Occhiaperti, L.; Di, R.R.; Ruggeri, V.; Donelli, G. Polyurethanes loaded with antibiotics: Influence of polymer-antibiotic interactions on in vitro activity against Staphylococcus epidermidis. J. Chemother. 2004, 16, 446-452.
10. Takai, M.; Uehara, Y.; Beisler, J.A. Usnic acid derivatives as potential antineoplastic agents. J. Med. Chem. 1979, 22, 1380-1384.
11. Song, Y.; Dai, F.; Zhai, D.; Dong, Y.; Zhang, J.; Lu, B.; Luo, J.; Liu, M.; Yi, Z. Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways. Angiogenesis 2012, 15, 421-432.
12. Backorova, M.; Backor, M.; Mikes, J.; Jendzelovsky, R.; Fedorocko, P. Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid. Toxicol. In Vitro 2011, 25, 37-44.
13. Mayer, M.; O'Neill, M.A.; Murray, K.E.; Santos-Magalhães, N.S.; Carneiro-Leao, A.M.; Thompson, A.M.; Appleyard, V.C. Usnic acid: A non-genotoxic compound with anti-cancer properties. Anticancer Drugs 2005, 16, 805-809.
14. Han, D.; Matsumaru, K.; Rettori, D.; Kaplowitz, N. Usnic acid-induced necrosis of cultured mouse hepatocytes: Inhibition of mitochondrial function and oxidative stress. Biochem. Pharmacol. 2004, 67, 439-451.
15. Guo, L.; Shi, Q.; Fang, J.L.; Mei, N.; Ali, A.A.; Lewis, S.M.; Leakey, J.E.; Frankos, V.H. Review of usnic acid and Usnea barbata toxicity. J. Environ. Sci. Health C 2008, 26, 317-338.
16. Craig, D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 2002, 231, 131-144.
17. Mahmud, A.; Xiong, X.B.; Aliabadi, H.M.; Lavasanifar, A. Polymeric micelles for drug targeting. J. Drug Target. 2007, 15, 553-584.
18. Pillai, O.; Panchagnula, R. Polymers in drug delivery. Curr. Opin. Chem. Biol. 2001, 5, 447-451.
19. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. 2003, 2, 347-360.
20. Kristmundsdottir, T.; Aradottir, H.A.; Ingolfsdottir, K.; Ogmundsdottir, M. Solubilization of the lichen metabolite (+)-usnic acid for testing in tissue culture. J. Pharm. Pharmacol. 2002, 54, 1447-1452.
21. Lira, M.C.; Ferraz, M.S.; da Silva, D.G.; Cortes, M.E.; Teixeira, K.I.; Caetano, N.P.; Sinisterra, R.D.; Ponchel, G.; Santos-Magalhães, N.S. Inclusion complex of usnic acid with B-cyclodextrin: characterization and nanoencapsulation into liposomes. J. Incl. Phenom. Macrocycl. Chem. 2009, 64, 215-224.
22. Da Silva Santos, N.P.; Nascimento, S.C.; Wanderley, M.S.; Pontes-Filho, N.T.; da Silva, J.F.; de Castro, C.M.; Pereira, E.C.; da Silva, N.H.; Honda, N.K.; Santos-Magalhães, N.S. Nanoencapsulation of usnic acid: An attempt to improve antitumour activity and reduce hepatotoxicity. Eur. J. Pharm. Biopharm. 2006, 64, 154-160.
23. Bazin, M.; Le Lamer, A.; Delcros, J.; Rouaud, I.; Uriac, P.; Boustie, J.; Corbel, J.; Tomasi, S. Synthesis and cytotoxic activities of usnic acid derivatives. Bioorgan. Med. Chem. 2008, 16, 6860-6866.
24. Kenawy, E.; Worley, S.D.; Broughton, R. The chemistry and applications of antimicrobial polymers: A state-of-the-art review. Biomacromolecules 2007, 8, 1359-1384.
25. Palermo, E.F.; Kuroda, K. Structural determinants of antimicrobial activity in polymers which mimic host defense peptides. Appl. Microbiol. Biotechnol. 2010, 87, 1605-1615.
26. Fischer D.; Lib Y.; Ahlemeyerc B.; Krieglsteinc J.; Kissela T. In vitro cytotoxicity testing of polycations: Influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24, 1121-1131.
27. Cherng, J.; van de Wetering, P.; Talsma, H.; Crommelin, D.J.A.; Hennink, W.E. Effect of size and serum proteins on transfection efficiency of poly (2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm. Res. 1996, 13, 1038-1042.
28. Salloum, D.S.; Olenych, S.G.; Keller, T.C.S.; Schlenoff, J.B. Vascular smooth muscle cells on polyelectrolyte multilayers: Hydrophobicity-directed adhesion and growth. Biomacromolecules 2005, 6, 161-167.
29. Davies, J.; Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 2010, 74, 417-433.
30. Francolini, I.; Donelli, G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol. Med. Microbiol. 2010, 59, 227-238.
31. Francolini, I.; Ruggeri, V.; Martinelli, A.; D'Ilario, L.; Piozzi, A. Novel metal-polyurethane complexes with enhanced antimicrobial activity. Macromol. Rapid. Comm. 2006, 27, 233-237.
32. Palermo, E.F.; Kuroda, K. Chemical structure of cationic groupsin amphiphilic polymethacrylates modulates the antimicrobial and hemolytic activities. Biomacromolecules 2009, 10, 1416-1428.